Butterbur
Common Names: butterbur, petasites, purple butterbur
Latin Names: Petasites hybridus (also known as Petasites officinalis or Tussilago hybrida)
Background
- Butterbur is a shrub that grows in Europe and parts of Asia and North America. The name, butterbur, is attributed to the traditional use of its large leaves to wrap butter in warm weather. The names for this plant in some other languages translate as “rain hat” or “hat plant,” reflecting another use of the large leaves.
- Butterbur has been used for health purposes for many centuries. In the Middle Ages, the odor and smoke from burning butterbur roots were thought to fight plague. Today, butterbur is promoted as a dietary supplement for migraine, allergic rhinitis (hay fever), and other conditions.
How Much Do We Know?
- There have been several studies of butterbur for migraines and allergic rhinitis (hay fever) in people, so we have some knowledge of its effects on these two conditions.
What Have We Learned?
- A butterbur root extract may reduce the frequency of migraines in adults and children when taken orally. In 2012, the American Academy of Neurology recommended butterbur for preventing migraines. However, the Academy stopped recommending it in 2015 because of serious concerns about its safety.
- Studies of a butterbur leaf extract suggest that it may be helpful for symptoms of allergic rhinitis when taken orally.
- Little research has been done on butterbur for conditions other than migraine and allergic rhinitis, and no conclusions can be reached about its effects for other conditions.
What Do We Know About Safety?
- The butterbur plant contains substances called pyrrolizidine alkaloids (PAs). PAs can damage the liver and lungs and may cause cancer. Only butterbur products that have been processed to remove PAs and are labeled or certified as PA-free should be considered for use.
- Several studies, including studies of children and adolescents, have reported that PA-free butterbur products seem to be safe when taken by mouth for up to 16 weeks. However, there have been rare cases of liver injury associated with products that were reported to be PA-free.
- Butterbur products that contain PAs may not be safe when applied to the skin. PAs could be absorbed through cuts or scrapes.
- Butterbur is generally well tolerated when taken orally. Side effects can include belching, diarrhea, drowsiness, rash, and stomach upset.
- Butterbur may cause an allergic reaction in people who are allergic to related plants, such as ragweed, chrysanthemums, marigolds, and daisies.
- If you take any type of medicine, talk with your health care provider before using butterbur or other herbal products; some herbs and medicines interact in harmful ways.
- Butterbur products with PAs should not be used during pregnancy or while breastfeeding because they may cause birth defects or liver damage. Little is known about whether it’s safe to use PA-free butterbur products during pregnancy or while breastfeeding.
Keep in Mind
- Take charge of your health—talk with your health care providers about any complementary health approaches you use. Together, you can make shared, well-informed decisions.
- Federal Regulation of Herbal Products
- Depending on what’s in them, how they’re intended to be used, and how they’re administered (orally or topically), herbal products are regulated in a variety of ways. Many herbal products intended for oral use are marketed as dietary supplements. The rules for making and distributing dietary supplements are less strict than those for drugs.
- Unlike drugs, dietary supplements are not approved by the U.S. Food and Drug Administration (FDA) before they are sold to the public. When public health concerns arise about the safety of a dietary supplement or an ingredient including an herb, the FDA can take action to protect the public. Manufacturers and distributors of supplements are responsible for evaluating the safety and labeling of their products before marketing to ensure that they meet all regulatory requirements.
NCCIH Clearinghouse
The NCCIH Clearinghouse provides information on NCCIH and complementary and integrative health approaches, including publications and searches of Federal databases of scientific and medical literature. The Clearinghouse does not provide medical advice, treatment recommendations, or referrals to practitioners.
Toll-free in the U.S.: 1-888-644-6226
Telecommunications relay service (TRS): 7-1-1
Website: https://www.nccih.nih.gov
Email: info@nccih.nih.gov (link sends email)
PubMed®
A service of the National Library of Medicine, PubMed® contains publication information and (in most cases) brief summaries of articles from scientific and medical journals. For guidance from NCCIH on using PubMed, see How To Find Information About Complementary Health Practices on PubMed.
Website: https://pubmed.ncbi.nlm.nih.gov/
Office of Dietary Supplements (ODS), National Institutes of Health (NIH)
ODS seeks to strengthen knowledge and understanding of dietary supplements by evaluating scientific information, supporting research, sharing research results, and educating the public. Its resources include publications (such as Dietary Supplements: What You Need To Know) and fact sheets on a variety of specific supplement ingredients and products (such as vitamin D and multivitamin/mineral supplements).
Website: https://ods.od.nih.gov
Email: ods@nih.gov (link sends email)
Key References
- Butterbur. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. National Institute of Diabetes and Digestive and Kidney Diseases. Updated February 18, 2019. Accessed at ncbi.nlm.nih.gov/books/NBK547997 on October 12, 2023.
- Butterbur. NatMed Pro website. Accessed at naturalmedicines.therapeuticresearch.com on September 27, 2023. [Database subscription].
- Holland S, Silberstein SD, Freitag F, et al. Evidence-based guidelines update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society [RETIRED]. Neurology. 2012;78(7):1346-1353.
- Kulinowski Ł, Luca SV, Minceva M, et al. A review on the ethnobotany, phytochemistry, pharmacology and toxicology of butterbur species (Petasites L.). Journal of Ethnopharmacology. 2022;293:115263.
This publication is not copyrighted and is in the public domain. Duplication is encouraged.
NCCIH has provided this material for your information. It is not intended to substitute for the medical expertise and advice of your health care provider(s). We encourage you to discuss any decisions about treatment or care with your health care provider. The mention of any product, service, or therapy is not an endorsement by NCCIH.